12-49051631-A-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_003482.4(KMT2D):​c.2052T>A​(p.Pro684Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000607 in 1,572,820 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00061 ( 4 hom. )

Consequence

KMT2D
NM_003482.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.289

Publications

0 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-49051631-A-T is Benign according to our data. Variant chr12-49051631-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.289 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000589 (88/149528) while in subpopulation SAS AF = 0.00403 (19/4714). AF 95% confidence interval is 0.00264. There are 0 homozygotes in GnomAd4. There are 44 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 88 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.2052T>A p.Pro684Pro synonymous_variant Exon 11 of 55 ENST00000301067.12 NP_003473.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.2052T>A p.Pro684Pro synonymous_variant Exon 11 of 55 5 NM_003482.4 ENSP00000301067.7
KMT2DENST00000683543.2 linkc.2052T>A p.Pro684Pro synonymous_variant Exon 11 of 56 ENSP00000506726.1
KMT2DENST00000685166.1 linkc.2052T>A p.Pro684Pro synonymous_variant Exon 10 of 54 ENSP00000509386.1
KMT2DENST00000692637.1 linkc.2052T>A p.Pro684Pro synonymous_variant Exon 10 of 54 ENSP00000509666.1

Frequencies

GnomAD3 genomes
AF:
0.000589
AC:
88
AN:
149422
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000498
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000199
Gnomad ASJ
AF:
0.00896
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00403
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0132
Gnomad NFE
AF:
0.000370
Gnomad OTH
AF:
0.00195
GnomAD2 exomes
AF:
0.000828
AC:
182
AN:
219750
AF XY:
0.000860
show subpopulations
Gnomad AFR exome
AF:
0.0000662
Gnomad AMR exome
AF:
0.0000932
Gnomad ASJ exome
AF:
0.00867
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000104
Gnomad NFE exome
AF:
0.000492
Gnomad OTH exome
AF:
0.000948
GnomAD4 exome
AF:
0.000608
AC:
866
AN:
1423292
Hom.:
4
Cov.:
37
AF XY:
0.000693
AC XY:
487
AN XY:
702774
show subpopulations
African (AFR)
AF:
0.0000304
AC:
1
AN:
32886
American (AMR)
AF:
0.000165
AC:
7
AN:
42416
Ashkenazi Jewish (ASJ)
AF:
0.00854
AC:
199
AN:
23306
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39330
South Asian (SAS)
AF:
0.00331
AC:
264
AN:
79710
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51712
Middle Eastern (MID)
AF:
0.00376
AC:
21
AN:
5582
European-Non Finnish (NFE)
AF:
0.000284
AC:
309
AN:
1089734
Other (OTH)
AF:
0.00109
AC:
64
AN:
58616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000589
AC:
88
AN:
149528
Hom.:
0
Cov.:
31
AF XY:
0.000603
AC XY:
44
AN XY:
73028
show subpopulations
African (AFR)
AF:
0.0000496
AC:
2
AN:
40284
American (AMR)
AF:
0.000199
AC:
3
AN:
15080
Ashkenazi Jewish (ASJ)
AF:
0.00896
AC:
31
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4986
South Asian (SAS)
AF:
0.00403
AC:
19
AN:
4714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10260
Middle Eastern (MID)
AF:
0.0143
AC:
4
AN:
280
European-Non Finnish (NFE)
AF:
0.000370
AC:
25
AN:
67486
Other (OTH)
AF:
0.00193
AC:
4
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
1

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dec 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D: BP4, BP7, BS1

not specified Benign:2
Apr 10, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Kabuki syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
8.3
DANN
Benign
0.59
PhyloP100
0.29
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200116899; hg19: chr12-49445414; API